Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis

Cheng S, Zhang Z, Hu C, Xing N, Xia Y, Pang B

OncoTargets and Therapy 2020, 13:6651-6660

Published Date: 7 July 2020